Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP90771.RAa3uDqGIaX0EojqzRQAYIXdFyTKKZH-ri3TTMv5QNoMU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP90771.RAa3uDqGIaX0EojqzRQAYIXdFyTKKZH-ri3TTMv5QNoMU130_assertion type Assertion NP90771.RAa3uDqGIaX0EojqzRQAYIXdFyTKKZH-ri3TTMv5QNoMU130_head.
- NP90771.RAa3uDqGIaX0EojqzRQAYIXdFyTKKZH-ri3TTMv5QNoMU130_assertion description "[Haplotype analysis supported an association of the cholecystokinin gene TG haplotype with the PD-all group (P = 0.04), whereas DRD1 receptor CAA and HTR2A receptor AT haplotypes were associated with a lower risk for PD-pure phenotype (P = 0.03 and P = 0.04, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90771.RAa3uDqGIaX0EojqzRQAYIXdFyTKKZH-ri3TTMv5QNoMU130_provenance.
- NP90771.RAa3uDqGIaX0EojqzRQAYIXdFyTKKZH-ri3TTMv5QNoMU130_assertion evidence source_evidence_literature NP90771.RAa3uDqGIaX0EojqzRQAYIXdFyTKKZH-ri3TTMv5QNoMU130_provenance.
- NP90771.RAa3uDqGIaX0EojqzRQAYIXdFyTKKZH-ri3TTMv5QNoMU130_assertion SIO_000772 15722953 NP90771.RAa3uDqGIaX0EojqzRQAYIXdFyTKKZH-ri3TTMv5QNoMU130_provenance.
- NP90771.RAa3uDqGIaX0EojqzRQAYIXdFyTKKZH-ri3TTMv5QNoMU130_assertion wasDerivedFrom gad-20150221 NP90771.RAa3uDqGIaX0EojqzRQAYIXdFyTKKZH-ri3TTMv5QNoMU130_provenance.
- NP90771.RAa3uDqGIaX0EojqzRQAYIXdFyTKKZH-ri3TTMv5QNoMU130_assertion wasGeneratedBy ECO_0000203 NP90771.RAa3uDqGIaX0EojqzRQAYIXdFyTKKZH-ri3TTMv5QNoMU130_provenance.